We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Colorimetric Assay Quantifies Urease Activity

By LabMedica International staff writers
Posted on 13 Nov 2013
A novel high throughput colorimetric urease activity assay was compared to the Nessler method and the new method employs phenol red to determine the urease activity.

This method is rapid, sensitive, easy, cost-effective, does not use any toxic chemical reagents, significantly reduces sample-processing time, and allows real-time investigations. More...


Scientists at the University of Houston (TX, USA) determine the urease activity of seven urease-positive (+) and two urease-negative (−) bacteria from diverse environmental sources. All cultures were incubated for 24 hours at 150 rpm (INNOVA 44, New Brunswick Scientific Co.; Enfield, CT, USA) in their specific growth conditions. The bacterial cells were then adjusted to an optical density of 0.5 at 600 nm with a plate reader.

Suspensions for all microorganisms were inoculated into Stuart's broth in triplicates into flat-bottom 96-well plate and read at 430 nm and 560 nm every 30 minutes for 24 hours with the Synergy MX Microtiter plate reader (BioTek; Winooski, VT, USA). To quantify the urease activity with this new method, the reaction rates were calculated from the absorbance data and they were correlated with the urease activity based on the standard curve of the urease enzyme. The results of this method were compared to the standard Nessler method.

The two methods showed related but not identical values. The Nessler method requires sample collection and preparation steps before measurement of the enzyme activity, but the new method does not, which could explain the slightly different results. In addition, it was found that filtration affects the enzymatic activity, which might be another possible cause for the observed variation between the two results.

The authors concluded that the new method is high throughput, it has decreased analysis processing, and provides a shorter assay work-up. These features make this method a good alternative to the Nessler method for rapid quantification and screening of urease activity. The study was published on October 5, 2103, in the Journal of Microbiological Methods.

Related Links:

University of Houston
New Brunswick Scientific Co. 
BioTek 



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image:Schematic illustration of plasmonic microarray–based KRAS mutation detection from colorectal cancer patients. (Lee, J.Y., Mun, C.W., Kim, E.R. et al. npj Precision Oncology, 2026. https://doi.org/10.1038/s41698-026-01452-8)

Blood and Urine Liquid Biopsy Detects Early Colorectal Cancer Mutations

Early-stage colorectal cancer is difficult to assess noninvasively because tumor-derived mutations occur at extremely low levels in blood and urine, straining the sensitivity, cost, and turnaround time... Read more

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.